Early Postoperative Magnetic Resonance in the Diagnosis of Persistent Juvenile Angiofibroma.
Adolescent
Adult
Angiofibroma
/ complications
Child
Clinical Decision-Making
Endoscopy
/ methods
Follow-Up Studies
Head and Neck Neoplasms
/ pathology
Humans
Magnetic Resonance Imaging
/ methods
Male
Natural Orifice Endoscopic Surgery
/ methods
Postoperative Period
Prospective Studies
Sensitivity and Specificity
Young Adult
Juvenile angiofibroma
magnetic resonance
persistent juvenile angiofibroma
postoperative magnetic resonance
transnasal endoscopic surgery
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
30
10
2020
received:
13
05
2020
accepted:
17
11
2020
pubmed:
28
11
2020
medline:
27
7
2021
entrez:
27
11
2020
Statut:
ppublish
Résumé
Despite improvements in the treatment of juvenile angiofibroma (JA), the rate of persistence (pJA) is still not negligible. In the present study, we assessed the value of early postoperative magnetic resonance imaging (MRI) in depicting unintentional pJAs and designed a MRI-driven decisional flow-chart for pJA management and follow-up. Observational study. Patients undergoing early postoperative MRI after endoscopic resection of JA in the Unit of Otorhinolaryngology - ASST Spedali Civili, University of Brescia from 2007 to 2017 were enrolled. MRI was defined as negative or positive based on defined radiological criteria. The diagnostic performance of MRI was evaluated. The analysis included 26 patients, with a mean age of 16.5 years (range, 11-25). Early MRI was negative for pJA in 21 (80.8%) patients and positive in five (19.2%). No patient with a negative finding was found positive at subsequent follow-up MRIs. The accuracy of a positive finding was confirmed by pathologic examination (three cases) or follow-up MRIs (two cases). The diagnostic performance of MRI was excellent with sensitivity and specificity of 100%. An MRI-driven flow-chart for pJA management and follow-up was designed. Early postoperative MRI demonstrated a high diagnostic accuracy in the detection of unintentional pJA. Our MRI-driven strategy and decisional flow-chart could aid in the decision-making process in the management of pJA and definition of postoperative surveillance. 4 Laryngoscope, 131:E2436-E2441, 2021.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
E2436-E2441Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2020 American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA).
Références
López F, Triantafyllou A, Snyderman CH, et al. Nasal juvenile angiofibroma: current perspectives with emphasis on management. Head Neck 2017;39:1033-1045.
Kulas P, Willnecker V, Dlugaiczyk J, Laschke MW, Schick B. Mesenchymal-endothelial transition in juvenile angiofibroma? Acta Otolaryngol 2015;135:955-961.
Nonogaki S, Campos HG, Butugan O, et al. Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas. Exp Ther Med 2010;1:921-926.
Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ. Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 2007;264:389-394.
Zhang M, Sun X, Yu H, Hu L, Wang D. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study. Acta Histochem 2011;113:626-630.
Coutinho-camillo CM, Brentani MM, Nagai MA. Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck 2008;30:390-400.
Pandey P, Mishra A, Tripathi AM, et al. Current molecular profile of juvenile nasopharyngeal angiofibroma: first comprehensive study from India. Laryngoscope 2017;127:E100-E106.
Mcknight CD, Parmar HA, Watcharotone K, Mukherji SK. Reassessing the anatomic origin of the juvenile nasopharyngeal Angiofibroma. J Comput Assist Tomogr 2017;41:559-564.
Nicolai P, Schreiber A, Bolzoni villaret A. Juvenile angiofibroma: evolution of management. Int J Pediatr 2012;2012:412545.
Lutz J, Holtmannspötter M, Flatz W, et al. Preoperative embolization to improve the surgical management and outcome of juvenile nasopharyngeal angiofibroma (JNA) in a single center: 10-year experience. Clin Neuroradiol 2016;26:405-413.
Snyderman CH, Pant H, Carrau RL, Gardner P. A new endoscopic staging system for angiofibromas. Arch Otolaryngol Head Neck Surg 2010;136:588-594.
Schreiber A, Bertazzoni G, Ferrari M, et al. Management of persistent juvenile angiofibroma after endoscopic resection: analysis of a single institution series of 74 patients. Head Neck 2019;41:1297-1303.
Boghani Z, Husain Q, Kanumuri VV, et al. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope 2013;123:859-869.
Rowan NR, Stapleton AL, Heft-neal ME, Gardner PA, Snyderman CH. The natural growth rate of residual juvenile angiofibroma. J Neurol Surg B Skull Base 2018;79:257-261.
Bertazzoni G, Schreiber A, Ferrari M, Nicolai P. Contemporary management of juvenile angiofibroma. Curr Opin Otolaryngol Head Neck Surg 2019;27:47-53.
Thakar A, Hota A, Bhalla AS, Gupta SD, Sarkar C, Kumar R. Overt and occult vidian canal involvement in juvenile angiofibroma and its possible impact on recurrence. Head Neck 2016;38:E421-5.
Howard DJ, Lloyd G, Lund V. Recurrence and its avoidance in juvenile angiofibroma. Laryngoscope 2001;111:1509-1511.
Hofmann T, Bernal-Sprekelsen M, Koele W, Reittner P, Klein E, Stammberger H. Endoscopic resection of juvenile angiofibromas - long term results. Rhinology 2005;43:282-289.
Kania RE, Sauvaget E, Guichard JP, Chapot R, Huy PT, Herman P. Early postoperative CT scanning for juvenile nasopharyngeal angiofibroma: detection of residual disease. AJNR Am J Neuroradiol 2005;26:82-88.
Lund VJ, Stammberger H, Nicolai P. Rhinol Suppl. 2010 Jun 1;22:1-143. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base.
Cloutier T, Pons Y, Blancal JP, et al. Juvenile nasopharyngeal angiofibroma: does the external approach still make sense? Otolaryngol Head Neck Surg 2012;147:958-963.
Safadi A, Schreiber A, Fliss DM, Nicolai P. Juvenile angiofibroma: current management strategies. J Neurol Surg B Skull Base 2018;79:21-30.
Nicolai P, Villaret AB, Farina D, et al. Endoscopic surgery for juvenile angiofibroma: a critical review of indications after 46 cases. Am J Rhinol Allergy 2010;24:e67-e72.
Tyagi I, Syal R, Goyal A. Recurrent and residual juvenile angiofibromas. J Laryngol Otol 2007;121:460-467.
Chagnaud C, Petit P, Bartoli J, et al. Postoperative follow-up of juvenile nasopharyngeal angiofibromas: assessment by CT scan and MR imaging. Eur Radiol 1998;8:756-764. https://doi.org/10.1007/s003300050468.
Mallick S, Benson R, Bhasker S, Mohanti BK. Conformal radiotherapy for locally advanced juvenile nasopharyngeal angio-fibroma. J Cancer Res Ther 2015;11:73-77.
Amdur RJ, Yeung AR, Fitzgerald BM, Mancuso AA, Werning JW, Mendenhall WM. Radiotherapy for juvenile nasopharyngeal angiofibroma. Pract Radiat Oncol 2011;1:271-278.
Chakraborty S, Ghoshal S, Patil VM, Oinam AS, Sharma SC. Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience. Int J Radiat Oncol Biol Phys 2011;80:1398-1404.
Park HH, Hong CK, Jung HH, et al. The role of radiosurgery in the Management of Benign Head and Neck Tumors. World Neurosurg 2016;87:116-123.
Gates GA, Rice DH, Koopmann CF, Schuller DE. Flutamide-induced regression of angiofibroma. Laryngoscope 1992;102:641-644.
Scholfield DW, Brundler MA, Mcdermott AL, Mussai F, Kearns P. Adjunctive treatment in juvenile nasopharyngeal Angiofibroma: how should we approach recurrence? J Pediatr Hematol Oncol 2016;38:235-239.
Thakar A, Gupta G, Bhalla AS, et al. Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head Neck 2011;33:1747-1753.
Le T, New J, Jones JW, et al. Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma. Int Forum Allergy Rhinol 2017;7:973-979.
Montag AG, Tretiakova M, Richardson M. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta. Am J Clin Pathol 2006;125:832-837.
Schick B, Dlugaiczyk J, Wendler O. Expression of sex hormone receptors in juvenile angiofibromas and antiproliferative effects of receptor modulators. Head Neck 2014;36:1596-1603.